LUCD

Lucid Diagnostics
LUCD

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$126.59M
EV
$190.21M
Shares Outstanding
112.96M
Beta
1.25

Wall Street View

Analyst Rating
BUY
Analyst Target Price
$3.79
P/E 2025E
-
P/Revenue 2025E
19.51x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Lucid Diagnostics Inc.

gainify
LUCD

Lucid Diagnostics Inc.

LUCD

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily high...

Sector

Healthcare

Industry

Medical - Devices

CEO

Aklog, Lishan

Employees

72

IPO Date

2021-10-14

Headquarters

360 Madison Avenue, 25th Floor, New York, New York, 10017, United States

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

COMPANY

Pricing

Dashboard

About Us

Contact Us

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.